I fully agree.......all OTC companies face the same issue of initial financing........its called gambling........... most dont make it....
IF one noticed this director's past history......that in itself is a reason to buy this stock IMHO
"Upper management in two premier startup Biotech Oraganizations. Genentech, 1986 - 1995, then snatched up to start up MedImmune :"Endorsers who were Kim’s colleagues at Genentech"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.